Industry
Global POC Diagnostics Market to Reach Nearly USD 90 Billion Due to Growing Demand for Rapid COVID-19 Test Kits
The global point of care (POC) diagnostics market is estimated to grow at a CAGR of 12.7% from approximately USD 36 billion in 2021 to nearly USD 90 billion in 2028, driven by the increasing prevalence of infectious diseases, product developments and launches, and rise in the number of CLIA-waived POC tests. However, product recalls are expected to hamper market growth. More...13 Dec 2021
Eurofins Acquires Genetic Lab Co. to Enhance Clinical and COVID-19 Testing Offering in Japan
Eurofins Scientific (Ebersberg, Germany) has entered into an agreement to acquire Genetic Lab Co., Ltd. (Japan), a molecular biology based testing provider for diagnostics, biomarker development and drug discovery. More...13 Dec 2021
Global Point-of-Care Coagulation Testing Market to Be Driven by Growing Geriatric Population
The global point-of-care (POC) coagulation testing market is set to achieve significant growth on the back of the growing geriatric population and increasing technological innovations in POC testing, although the lack of trained professionals will hamper market growth. More...08 Dec 2021
Global HBA1c Laboratory Tests Market Driven by Rise in Diabetic Population
The global HBA1c laboratory tests market is projected to expand at a significant pace over the coming years, driven by an increase in the prevalence of diabetes, rise in prescription rate of HBA1c tests by physicians, low price of tests, and awareness about complications of high diabetes levels. More...03 Dec 2021
Siemens Partners with Biotech Company Freenome to Develop Blood Test for Early Breast Cancer Detection
Siemens Healthineers (Erlangen, Germany) and Freenome (South San Francisco, CA, USA) have entered into a collaboration in multiomics and radiomic breast cancer diagnostics to identify suitable markers for early breast cancer detection through blood to augment existing imaging technologies. More...02 Dec 2021
Global Lateral Flow Assay Market to Reach Nearly USD 6.5 Billion by 2031 Due to Surge in Demand for Rapid POC Testing
The global lateral flow assay market is projected to grow at a CAGR of around 5% from USD 3.7 billion in 2020 to over USD 6.4 billion by 2031, driven by the growing adoption of home-based lateral flow assay kits, demand growth of point-of-care testing, and rise in adoption of LFA kits due to their advantages over laboratory tests. More...01 Dec 2021
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Repetitive Pipette
VWR® Stepper Pro
In Other News
Global Chemiluminescence Immunoassay (CLIA) Analyzers Market to Surpass USD 7.5 Billion by 2025
Global Point of Care Diagnostics Market to Top USD 35 Billion by 2027 Due to Rising Diabetic Cases
Euromedlab Congress 2021 Postponed as Fourth COVID-19 Wave Hits Germany
MEDICA 2021 + COMPAMED 2021 Re-Launches In-Person with Innovations Galore for Outpatient and Inpatient Care
Blood Borne Testing Market to Witness Exponential Growth Due to Rising Incidence of Bacterial Infections
Rapid Medical Diagnostic Kits Market to Top USD 23 Billion by 2031 due to Successive Outbreaks of Novel Contagious Viruses
Global qPCR Instruments Market to Touch USD 1.4 Billion by 2028 on Back of Spike in COVID-19 Infections
Global Point-of-Care (POC) Testing Market to Reach Nearly USD 80 Billion by 2028 due to Increasing Dominance of Infectious Diseases
Certest Offers Real-Time PCR Assays for Fast Detection of MDR Bacterial Infections
Global Digital Polymerase Chain Reaction (dPCR) Market Projected to Reach Close to USD 1.15 Billion by 2028
Mesa Laboratories to Acquire Molecular Diagnostics Tools Company Agena Bioscience
Global Blood, Gas and Electrolyte Analyzers Market Projected to Reach Nearly USD 3.5 Billion by 2023
Global In Vitro Diagnostics (IVD) Quality Control Market Projected to Reach USD 1.4 Billion by 2026
Global COVID-19 Saliva-Based Screening Market to Continue Growing Due to Ease of Use and Shorter Test-to-Result
Global Hematology Testing Instrument Market Driven by Growing Demand for Preventive Diagnosis and Treatment Monitoring
Global Urinalysis Market Projected to Reach Nearly USD 5 Billion by 2026
Novel Artificial Intelligence (AI) Blood Test Can Detect Over 90% of Lung Cancers
Global Point of Care Diagnostics Market Expected to Reach USD 71 Billion in 2027
Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test
BioCheck Acquires IVD Company DRG International
Global Blood Gas and Electrolyte Analyzers Market to Surpass USD 2 Billion by 2023
ELITechGroup Acquires Freezing Point Osmometry Provider GONOTEC
DiaSorin Completes Acquisition of Luminex to Become a Full-Fledged Diagnostic and Life Science Player
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
